source
- Reigniting Your Curiosity During FellowshipMegan M. Dupuis, MD, PhD, discusses how oncology fellows can keep their personal and professional curiosities alive during fellowship.onclive · 2mo ago↗ source
- Angelini fortifies neurology portfolio with $4.1B buyout of CatalystAngelini Pharma is spending $4.1 billion to buy Catalyst Pharmaceuticals and its trio of FDA-approved treatments for rare neurological diseases. The buyout will add three medicines to Angelini’s po…Endpoints · 2mo ago↗ source
- MANEUVER Trial Underscores Potential Paradigm Shift Toward Targeted Approaches in TGCTR. Lor Randall, MD, FACS, discusses how the introduction of systemic therapies like pimicotinib in TGCT enables a tumor biology–informed approach to care.onclive · 2mo ago